NOD2 and Crohn’s Disease: Loss or Gain of Function?
- 1 June 2005
- Vol. 22 (6) , 661-667
- https://doi.org/10.1016/j.immuni.2005.06.004
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AI61712, DK35108, RR17030)
- Crohn's and Colitis Foundation of America
This publication has 50 references indexed in Scilit:
- Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's diseaseThe Lancet, 2005
- The 3020insC allele of NOD2 predisposes to early-onset breast cancerBreast Cancer Research and Treatment, 2005
- The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMOCurrent Biology, 2004
- Treatment of inflammatory bowel disease with antibioticsGastroenterology Clinics of North America, 2004
- Inflammatory Bowel Disease Gene Hunting by Linkage AnalysisInflammatory Bowel Diseases, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB PathwayJournal of Molecular Biology, 2003
- Nod1, a CARD protein, enhances pro-interleukin-1β processing through the interaction with pro-caspase-1Biochemical and Biophysical Research Communications, 2002
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Activation of nuclear factor kappa B in inflammatory bowel diseaseGut, 1998